Baxter International Inc.

Joseph Edward Curtis

Sam L Helgerson

Roger L Lundblad

Shu-Len Liu

A method for preparing a purified and stable activated human Factor VIII composition is disclosed. A purified and stable activated human Factor VIII composition having a specific activity of at least 100,000 units per mg protein, or a potency of at least 15,000 units per ml is also disclosed.

Activated human factor VIII and method of preparation

Stabilized and activated Factor VIII is used as a therapeutic agent to treat patients with a Factor VIII deficiency. This includes hemophilia A patients as well as patients with Factor VIII inhibitors which block the hemostatic activity of Factor VIII. The stabilized and activated Factor VIII is also prepared in a therapeutic composition with a therapeutically acceptable adjuvant.

Growing community of inventors

Glendora, CA, United States of America

Joseph Edward Curtis